SII tells Centre it can supply 1 crore doses of qHPV vaccine against cervical cancer by December
New Delhi: Serum Institute of India has informed the Centre that it can supply 1 crore doses of its indigenously ...
Read moreDetailsNew Delhi: Serum Institute of India has informed the Centre that it can supply 1 crore doses of its indigenously ...
Read moreDetailsNew Delhi: Over 100 crore Covishield doses have been given in India and abroad which is a testimony of itssafety ...
Read moreDetailsNew Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for ...
Read moreDetailsGeneva: The World Health Organisation has given emergency approval to a coronavirus vaccine made by US-based Novavax and the Serum ...
Read moreDetailsNew Delhi: With not enough orders for Covishield from the central government, Serum Institute of India (SII) CEO Adar Poonawalla ...
Read moreDetailsNew Delhi: No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government ...
Read moreDetailsNew Delhi: The Health Ministry Monday said that 100 per cent advance of Rs 1732.50 crore was released to the ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla has been in the United Kingdom (UK) on extended stay. ...
Read moreDetailsLondon: Serum Institute of India CEO Adar Poonawalla Saturday spoke out about the pressures he was under over the production ...
Read moreDetailsNew Delhi: The Serum Institute of India (SII) Saturday broke its silence over the pricing of its Covid-19 vaccine 'Covishield' ...
Read moreDetails